Natalizumab in cerebrospinal fluid and breastmilk of patients with multiple sclerosis.
Ilaria CallegariMika SchneiderVera AebischerMargarete M VoortmanUndine ProschmannTjalf ZiemssenRaija LindbergBettina Fischer-BarnicolMichael KhalilLudwig KapposJens KuhleNicholas S R SandersonTobias DerfussPublished in: Therapeutic advances in neurological disorders (2023)
Routine use of such an assay would enable a better understanding of the safety of therapeutic antibody administration during pregnancy and lactation.